Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors
暂无分享,去创建一个
S. Severi | R. Calogero | G. Paganelli | F. Foca | I. Grassi | F. Nicolini | M. Bocchini | M. Tazzari | J. Schrader | S. Ravaioli | M. Mazza | M. Tebaldi | F. Piccinini | Maddalena Arigoni